Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
26,779 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...
House appropriators moved a fiscal 2027 THUD bill that preserves key housing programs but hints at reductions elsewhe...
Earnings season is winding down, but the real story is what company leaders say about the road ahead. This guide help...
Bitcoin outpaced Solana over the past five years on a total-return basis, but SOL delivered sharper upside during tec...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
Caesars Entertainment moves to go private in a $17.6 billion deal, and investors are eyeing four lagging U.S. compani...
The 2026 teen job outlook is grim, with hundreds teens flooding work as retailers and pools trim hiring. Experts warn...
The Zcash network halted block production for more than four hours, leaving thousands of transactions stranded and se...
May's initial jobless claims rose to a four-month high, but the spike is tied to Memorial Day timing rather than a br...
ASML’s stock rally has outpaced the broader market as AI-driven capex and a tightly controlled EUV backbone push back...
An overlooked cleantech fund just delivered a powerful start to 2026, posting double-digit gains year-to-date and ecl...